Law to Business Transitions - London Alumni Panel
22 November 2017
Panel discussion featuring London based alumni Mandy DeFilippo (MD Fixed Income - Morgan Stanley), Allan Hennings (Chairman - Boston Medical) and Mathias Strasser (CEO - Wallstreet Docs) who will share their experiences transitioning from law to business. This event is geared towards recent to mid-career graduates, but all are welcome.
Generously hosted by the partners of Shearman & Sterling LLP.
Arrival and networking drinks: 7pm to 7:30pm
Panel discussion: 7:30pm to 8:30pm
Post event networking drinks: 8:30 pm to 10pm
Where: Shearman & Sterling LLP
9 Appold Street
Please RSVP here if you plan to attend.
Mandy DeFilippo, is a Managing Director and Head of Risk Management for Fixed Income & Commodities, EMEA at Morgan Stanley. Mandy joined Morgan Stanley in 2007, in the Global Capital Markets division, based in London. She first worked in the Equity Capital Markets team, and from 2011 until 2013, she ran the Capital Markets Structuring Team in GCM EMEA for both debt and equity products. From 2013 until the beginning of 2017, Mandy was Chief Operating Officer for Global Capital Markets in EMEA, and Chief Risk Officer for GCM International, covering EMEA, Asia-Pacific and Japan. In her current role, Mandy sits on the EMEA Operating Committee for the Fixed Income Division, and on a number of other governance related committees in the Firm, including global and regional Franchise Committees and regional Risk Committees. Before joining Morgan Stanley, Mandy was a US corporate and securities lawyer at one of the "Magic Circle" law firms in London. Mandy holds a BA degree from Columbia University and a Juris Doctor degree from Harvard Law School.
Mathias Strasser is the founder and Chief Executive Officer of WallStreetDocs Ltd. (WSD). WSD was founded in 2009 and has a staff of approximately 50 in London, New York and Indonesia. WSD provides document automation services for structured products and OTC derivatives to financial institutions across the world. In 2017, WSD started a subsidiary called RegXchange Ltd. (RegX), which specializes in the exchange of regulatory documents and MiFID II information between sell-side and buy-side financial institutions. WSD is also currently in the process of preparing the launch of Transparitrade, a multi-issuer derivatives platform aimed at the U.S. market. Prior to starting WallStreetDocs, Mathias worked for Sullivan & Cromwell, first as an Associate and later as a European Counsel, where he gained extensive experience in all aspects of U.S. and European capital markets, MA and private equity law. Mathias holds an LL.M. degree from Harvard Law School and Mag. Iur. And Dr. Iur. degrees from Vienna University and is fluent in English and German. He is a frequent speaker at industry conferences on matters relating to structured products and OTC derivatives.
Allan Hennings is a Peruvian-born, London-based entrepreneur, angel investor and art patron. He is the founder and chairman of Boston Medical Group, a medical business that specialises in the treatment of male sexual dysfunctions. In 2017, the company celebrated their 20th anniversary of operations in Latin America and Spain where it has nearly 200 medical centres and has treated more than one million patients, making it the world leader in this sector. Allan was co-owner of the Inca Rail, a railway offering touristic transportation from Cuzco to Machu Pichu, a business sold to American investment firm The Carlyle Group in 2016. After a successful exit, he became interested in the world of startups, and he is now mentoring and supporting a few early-stage companies. Allan studied the LLM at HLS in 1989 and an MBA at IESE in 2009, and sits at HLS's Leadership Council of Europe. While in London, he has become involved in art collecting and patronage. Allan enjoys playing golf and researching about clean energy developments.
Arvin Abraham is EMEA Head of Governance for Retail Structured Products at Morgan Stanley and a Vice President in the Derivatives business. At Morgan Stanley, Arvin is responsible for regulatory change, platform design and strategy around how complex derivatives can be sold to retail clients. Arvin also has a leading role in new technology implementation for the structured notes business.
Prior to Morgan Stanley, Arvin worked for Sullivan & Cromwell in London. Arvin holds a J.D., magna cum laude, from Harvard Law School (Class of 2009) and an LLM in Commercial Law from the University of Cambridge.